Delivery Order SPE2DB22D1103-SPE2DB24FTRX6

Award Date 9/24/24
Potential Completion Date 9/25/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,211.41 firm fixed-price delivery order is for VEVYE 0.1% eye drops, 2ml, with an ultimate completion date of April 3, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is for the delivery of VEVYE 0.1% EYE DROP 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,448.71 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through June 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is a firm fixed price delivery order worth $14,390.05, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the supply of a pharmaceutical product, "VEVYE 0.1% EYE DROP 2ML," with a period of performance through April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is associated with a larger indefinite delivery contract (IDC) with DLA valued...
This federal contract award, valued at $1,713.56, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of VEVYE 0.1% EYE DROP 2ML, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of November 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,564.51 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4567039243 ! VEVYE 0.1% EYE DROP 2ML, with a period of performance through January 27, 2025. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,083.16 fixed-price delivery order is for the supply of a specific pharmaceutical product, VEVYE 0.1% eye drops, with a performance period ending on May 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,338.59, is for the delivery of a pharmaceutical product called "4567557411 ! VEVYE 0.1% EYE DROP 2ML". The contract is a Firm Fixed Price Delivery Order with a period of performance through March 13, 2025. There is no set-aside designation for this award. The contract is part of a larger...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,172.80 firm fixed-price delivery order is for VEVYE 0.1% eye drops, with a period of performance through March 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,946.90 firm fixed-price delivery order is for 4566383550 ! VEVYE 0.1% EYE DROP 2ML, with a completion date of November 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,642.59 and is for the delivery of 4566825304 ! VEVYE 0.1% EYE DROP 2ML. This is a firm fixed-price delivery order contract with a completion date of January 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTRX6
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,629.70 firm-fixed-price delivery order is for the supply of "VEVYE 0.1% EYE DROP 2ML" medical products, with a period of performance through September 25, 2024. The award is not designated under any set-aside program. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract award data indicates that Amerisourcebergen has extensive experience providing critical care materials and prescription drugs to various federal agencies, including the Department of Justice Federal Bureau of Investigation.

Generated 12/24/24, 9:14 AM